To further substantiate the role of histidine metabolism in the response to B-ALL treatment, the expression levels of the main enzymes involved in histidine catabolism (HAL, UROC, AMDHD, and FTCD) were examined. The gene discussed is FTCD; the disease is precursor B-cell acute lymphoblastic leukemia.